Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Nathalie De Vos"'
Autor:
Stephanie André, Anne-Violette Bruyneel, Audrey Chirumberro, Alain Roman, Marc Claus, Stephane Alard, Nathalie De Vos, Marie Bruyneel
Publikováno v:
American Journal of Medicine Open, Vol 10, Iss , Pp 100055- (2023)
Background: In COVID-19 intensive care unit (ICU)–admitted patients, multiorgan acute complications lead to long-lasting sequelae. The aim of this study was to assess (1) changes in chest CT, pulmonary function test (PFT), functional capacity (6-mi
Externí odkaz:
https://doaj.org/article/c9b33f9e7b844d09b5f8573afd0e02e7
Autor:
Valéry Daubie, Houssein Chalhoub, Bob Blasdel, Hafid Dahma, Maya Merabishvili, Tea Glonti, Nathalie De Vos, Johan Quintens, Jean-Paul Pirnay, Marie Hallin, Olivier Vandenberg
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
As the global burden of disease caused by multidrug resistant bacteria is a major source of concern, credible clinical alternatives to antibiotic therapy, such as personalized phage therapy, are actively explored. Although phage therapy has been used
Externí odkaz:
https://doaj.org/article/ba45576ef127413daba03e7c6a2edb61
Autor:
Philomène Lavis, Sofia Morra, Carmen Orte Cano, Nurhan Albayrak, Véronique Corbière, Véronique Olislagers, Nicolas Dauby, Véronique Del Marmol, Arnaud Marchant, Christine Decaestecker, Françoise Mascart, Nathalie De Vos, Philippe Van de Borne, Isabelle Salmon, Myriam Remmelink, Marc Parmentier, Alessandra Kupper Cardozo, Benjamin Bondue
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundChemerin is an extracellular protein with chemotactic activities and its expression is increased in various diseases such as metabolic syndrome and inflammatory conditions. Its role in lung pathology has not yet been extensively studied but
Externí odkaz:
https://doaj.org/article/82fabf54a5494ca4abcea9a910de8d4e
Autor:
Cecile Dusart, Jelle Smet, Audrey Chirumberro, Stephanie André, Alain Roman, Marc Claus, Anne-Violette Bruyneel, Ophelie Menez, Stephane Alard, Nathalie De Vos, Marie Bruyneel
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 11, p 3712 (2023)
Introduction: Despite improved management of patients with COVID-19, we still ignore whether pharmacologic treatments and improved respiratory support have modified outcomes for intensive care unit (ICU) surviving patients of the three first consecut
Externí odkaz:
https://doaj.org/article/3e9f635f7a3e4a91bca7141e05605580
Autor:
Laurent Truffaut, Lucas Demey, Anne Violette Bruyneel, Alain Roman, Stephane Alard, Nathalie De Vos, Marie Bruyneel
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-6 (2021)
Abstract Lung function impairment persists in 55% of critical COVID-19 patients three months after ICU discharge. Patient lung function, exercise capacity, radiologic, and quality of life data suggest impairment is related to radiologic lung involvem
Externí odkaz:
https://doaj.org/article/c5f4db0b65c14462a01b58d6d6b09436
Autor:
Nicolas Yin, Cyril Debuysschere, Marc Decroly, Fatima-Zohra Bouazza, Vincent Collot, Charlotte Martin, Fanny Ponthieux, Hafid Dahma, Marius Gilbert, Magali Wautier, Cecile Duterme, Nathalie De Vos, Marie-Luce Delforge, Stefano Malinverni, Frédéric Cotton, Magali Bartiaux, Marie Hallin
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: Since the first wave of COVID-19 in Europe, new diagnostic tools using antigen detection and rapid molecular techniques have been developed. Our objective was to elaborate a diagnostic algorithm combining antigen rapid diagnostic tests,
Externí odkaz:
https://doaj.org/article/682f6abf2ac74c1f87dfd4a9502bb4b6
Autor:
Pascal Mertens, Nathalie De Vos, Delphine Martiny, Christian Jassoy, Ali Mirazimi, Lize Cuypers, Sigi Van den Wijngaert, Vanessa Monteil, Pierrette Melin, Karolien Stoffels, Nicolas Yin, Davide Mileto, Sabrina Delaunoy, Henri Magein, Katrien Lagrou, Justine Bouzet, Gabriela Serrano, Magali Wautier, Thierry Leclipteux, Marc Van Ranst, Olivier Vandenberg, LHUB-ULB SARS-CoV-2 Working Diagnostic Group, Béatrice Gulbis, Françoise Brancart, François Bry, Brigitte Cantinieaux, Francis Corazza, Fréderic Cotton, Maud Dresselhuis, Bhavna Mahadeb, Olivier Roels, Jacques Vanderlinden
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Introduction: COVID-19 Ag Respi-Strip, an immunochromatographic (ICT) assay for the rapid detection of SARS-CoV-2 antigen on nasopharyngeal specimen, has been developed to identify positive COVID-19 patients allowing prompt clinical and quarantine de
Externí odkaz:
https://doaj.org/article/d6149371a1bf40d7972675915ca12a9a
Autor:
Ann Verdonck, Alain Roman, Jan Y Verbakel, Marc Moens, Laurent Blairon, Bob Braekevelt, Lieve Van Hoovels, Dragos Barglazan, Bart Peeters, Joris Penders, Damien Gruson, Jef Jonckheere, Viviane Van Hoof, Alain Verstraete, Florent Vanstapel, Katrien Lanckmans, Nathalie De Vos, Regis Debois
Publikováno v:
Acta clinica Belgica
Acta Clinica Belgica
Acta clinica Belgica, Vol. 77, no. 2, p. 329-336 (2022)
ACTA CLINICA BELGICA
Acta Clinica Belgica
Acta clinica Belgica, Vol. 77, no. 2, p. 329-336 (2022)
ACTA CLINICA BELGICA
Background There is a trend towards decentralisation of laboratory tests by means of Point-of-Care testing (POCT). Within hospitals, Belgian law requires a POCT policy, coordinated by the clinical laboratory. There is however no legal framework for P
Autor:
Cecile Dusart, Jelle Smet, Audrey Chirumberro, Stephanie André, David De Bels, Alain Roman, Marc Claus, Anne Violette Bruyneel, Ophelie Menez, Stephane Alard, Nathalie De Vos, Marie Bruyneel
Introduction Despite improvements in the management of COVID-19 patients, we still don’t know whether pharmacological treatments and improvements in ventilatory support have changed outcomes for intensive care unit (ICU) survivors of the three cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65585a88c05126b4f7f851ed512e5ffa
https://doi.org/10.21203/rs.3.rs-1384691/v1
https://doi.org/10.21203/rs.3.rs-1384691/v1
Autor:
Patrice Dufour, Justine Courtois, Adrien Nizet, Stéphanie Peeters, Jordi Farre-Segura, Caroline Le Goff, Violeta Stojkovic, Nathalie De Vos, Etienne Cavalier
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 58:1002-1009
Historically, the determination of low concentration analytes was initially made possible by the development of rapid and easy-to-perform immunoassays (IAs). Unfortunately, typical problems inherent to IA technologies rapidly appeared (e.g. elevated